• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓性肌萎缩症上肢模块修订版:新模块的开发

Revised upper limb module for spinal muscular atrophy: Development of a new module.

作者信息

Mazzone Elena S, Mayhew Anna, Montes Jacqueline, Ramsey Danielle, Fanelli Lavinia, Young Sally Dunaway, Salazar Rachel, De Sanctis Roberto, Pasternak Amy, Glanzman Allan, Coratti Giorgia, Civitello Matthew, Forcina Nicola, Gee Richard, Duong Tina, Pane Marika, Scoto Mariacristina, Pera Maria Carmela, Messina Sonia, Tennekoon Gihan, Day John W, Darras Basil T, De Vivo Darryl C, Finkel Richard, Muntoni Francesco, Mercuri Eugenio

机构信息

Department of Paediatric Neurology, Catholic University, Largo Gemelli 8, 00168, Rome, Italy.

Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.

出版信息

Muscle Nerve. 2017 Jun;55(6):869-874. doi: 10.1002/mus.25430. Epub 2017 Feb 6.

DOI:10.1002/mus.25430
PMID:27701745
Abstract

INTRODUCTION

There is a growing need for a robust clinical measure to assess upper limb motor function in spinal muscular atrophy (SMA), as the available scales lack sensitivity at the extremes of the clinical spectrum. We report the development of the Revised Upper Limb Module (RULM), an assessment specifically designed for upper limb function in SMA patients.

METHODS

An international panel with specific neuromuscular expertise performed a thorough review of scales currently available to assess upper limb function in SMA. This review facilitated a revision of the existing upper limb function scales to make a more robust clinical scale.

RESULTS

Multiple revisions of the scale included statistical analysis and captured clinically relevant changes to fulfill requirements by regulators and advocacy groups.

CONCLUSIONS

The resulting RULM scale shows good reliability and validity, making it a suitable tool to assess upper extremity function in the SMA population for multi-center clinical research. Muscle Nerve 55: 869-874, 2017.

摘要

引言

由于现有的评估量表在临床症状谱的两端缺乏敏感性,因此越来越需要一种可靠的临床测量方法来评估脊髓性肌萎缩症(SMA)患者的上肢运动功能。我们报告了修订后的上肢模块(RULM)的开发情况,这是一种专门为SMA患者上肢功能设计的评估方法。

方法

一个具有特定神经肌肉专业知识的国际小组对目前可用于评估SMA患者上肢功能的量表进行了全面审查。这次审查促进了对现有上肢功能量表的修订,以形成一个更可靠的临床量表。

结果

该量表经过多次修订,包括统计分析,并捕捉到了临床上相关的变化,以满足监管机构和倡导团体的要求。

结论

最终得到的RULM量表显示出良好的信度和效度,使其成为评估SMA人群上肢功能以进行多中心临床研究的合适工具。《肌肉与神经》55: 869 - 874, 2017年。

相似文献

1
Revised upper limb module for spinal muscular atrophy: Development of a new module.脊髓性肌萎缩症上肢模块修订版:新模块的开发
Muscle Nerve. 2017 Jun;55(6):869-874. doi: 10.1002/mus.25430. Epub 2017 Feb 6.
2
Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes.脊髓性肌萎缩症非行走患者的上肢模块:12个月的变化
Neuromuscul Disord. 2015 Mar;25(3):212-5. doi: 10.1016/j.nmd.2014.11.008. Epub 2014 Nov 22.
3
Revised upper limb module for spinal muscular atrophy: 12 month changes.上肢模块修订版治疗脊髓性肌萎缩症:12 个月的变化。
Muscle Nerve. 2019 Apr;59(4):426-430. doi: 10.1002/mus.26419. Epub 2019 Feb 7.
4
Assessing upper limb function in nonambulant SMA patients: development of a new module.评估非卧床型 SMA 患者的上肢功能:新模块的开发。
Neuromuscul Disord. 2011 Jun;21(6):406-12. doi: 10.1016/j.nmd.2011.02.014. Epub 2011 Mar 21.
5
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.脊髓性肌萎缩功能综合评分:脊髓性肌萎缩的一种功能测量方法。
Muscle Nerve. 2015 Dec;52(6):942-7. doi: 10.1002/mus.24670. Epub 2015 Oct 10.
6
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes.修订后的 II 型和 III 型脊髓性肌萎缩上肢模块:24 个月的变化。
Neuromuscul Disord. 2022 Jan;32(1):36-42. doi: 10.1016/j.nmd.2021.10.009. Epub 2021 Nov 7.
7
Different trajectories in upper limb and gross motor function in spinal muscular atrophy.脊髓性肌萎缩症上肢和粗大运动功能的不同轨迹。
Muscle Nerve. 2021 Nov;64(5):552-559. doi: 10.1002/mus.27384. Epub 2021 Aug 9.
8
Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy.5q 型脊髓性肌萎缩症成年患者评估用运动和功能量表的验证。
Eur J Neurol. 2022 Dec;29(12):3666-3675. doi: 10.1111/ene.15542. Epub 2022 Sep 13.
9
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.在接受nusinersen 治疗的非瘫痪型 2 型和 3 型 SMA 患儿中上肢功能得到改善:前瞻性 3 年 SMArtCARE 登记研究。
Orphanet J Rare Dis. 2022 Oct 23;17(1):384. doi: 10.1186/s13023-022-02547-8.
10
Assessment of the upper limb function, strength, and mobility in treatment-naive children with spinal muscular atrophy Types 2 and 3.对未经治疗的2型和3型脊髓性肌萎缩症儿童的上肢功能、力量和活动能力的评估。
Muscle Nerve. 2024 Mar;69(3):340-348. doi: 10.1002/mus.28041. Epub 2024 Jan 18.

引用本文的文献

1
Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study.神经元五聚体蛋白2作为成人脊髓性肌萎缩症患者对诺西那生治疗反应的潜在生物标志物:一项初步研究
Biomedicines. 2025 Jul 25;13(8):1821. doi: 10.3390/biomedicines13081821.
2
Spinal Muscular Atrophy Functional Composite Score Revised (SMA-FCR) in Untreated and Nusinersen-Treated Patient Cohorts.未治疗和接受诺西那生治疗的患者队列中的脊髓性肌萎缩症功能综合评分修订版(SMA-FCR)
Neurology. 2025 Jul 22;105(2):e213839. doi: 10.1212/WNL.0000000000213839. Epub 2025 Jun 27.
3
Oral function tests in spinal muscular atrophy: closing the diagnostic gap in severely affected adult patients : A prospective observational study.
脊髓性肌萎缩症的口腔功能测试:弥合重度成年患者的诊断差距:一项前瞻性观察性研究
J Orofac Orthop. 2025 Jun 24. doi: 10.1007/s00056-025-00597-8.
4
Italian validation of the SMA independence scale-upper limb module.SMA独立量表上肢模块的意大利语验证
Eur J Pediatr. 2025 Jun 10;184(7):410. doi: 10.1007/s00431-025-06207-4.
5
Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers.与脊髓性肌萎缩症患者及其照料者相关的患者报告结局的初步心理测量学验证。
Orphanet J Rare Dis. 2025 Jun 4;20(1):274. doi: 10.1186/s13023-025-03832-y.
6
Long-Term Effects of Nusinersen Dosing Frequency on Adult Patients With Spinal Muscular Atrophy: Efficacy of a 6-Month Dosing Interval.诺西那生钠给药频率对成年脊髓性肌萎缩症患者的长期影响:6个月给药间隔的疗效
Brain Behav. 2025 May;15(5):e70528. doi: 10.1002/brb3.70528.
7
Rehabilitation improves the effectiveness of nusinersen in children with type 2 spinal muscular atrophy: pNF-H and muscle MRI as potential biomarkers.康复治疗可提高2型脊髓性肌萎缩症患儿使用诺西那生钠的疗效:磷酸化神经丝蛋白重链和肌肉磁共振成像作为潜在生物标志物
Front Neurol. 2025 Apr 11;16:1549587. doi: 10.3389/fneur.2025.1549587. eCollection 2025.
8
Analysis of Eye Movements in Adults with Spinal Muscular Atrophy.脊髓性肌萎缩症成人患者的眼球运动分析
Medicina (Kaunas). 2025 Mar 23;61(4):571. doi: 10.3390/medicina61040571.
9
Enhancing the effects of nusinersen with cybernic treatment using Hybrid Assistive Limb (HAL) in spinal muscular atrophy: a real-world case series and exploratory cohort analysis.使用混合辅助肢体(HAL)的控制论治疗增强脊髓性肌萎缩症中诺西那生的疗效:一项真实世界病例系列和探索性队列分析
Orphanet J Rare Dis. 2025 Apr 23;20(1):194. doi: 10.1186/s13023-025-03681-9.
10
Upper limb motor function in individuals with SMA type 2: natural history and impact of therapies.2型脊髓性肌萎缩症患者的上肢运动功能:自然病史及治疗影响
J Neurol. 2025 Apr 9;272(5):331. doi: 10.1007/s00415-025-13042-y.